Monopar Therapeutics Inc. (MNPR)
NASDAQ · Healthcare
Monopar Therapeutics Inc. Cash on Hand 2016–2025
Monopar Therapeutics Inc. annual cash on hand history from 2016 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Monopar Therapeutics Inc. cash on hand as of December 31, 2025: 61.8M, a 34.96% increase year-over-year.
- Monopar Therapeutics Inc. cash on hand for 2025 were 61.8M, a 34.96% increase from 2024.
- Monopar Therapeutics Inc. cash on hand for 2024 were 45.8M, a 246.73% increase from 2019.
- Monopar Therapeutics Inc. cash on hand for 2019 were 13.2M, a 91.71% increase from 2018.
- Monopar Therapeutics Inc. cash on hand for 2018 were 6.9M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Monopar Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $62 |
| 2024 | $46 |
| 2019 | $13 |
| 2018 | $7 |
| 2017 | $9 |
| 2016 | $2 |
Monopar Therapeutics Inc. Cash on Hand — FAQ
Monopar Therapeutics Inc. (MNPR) cash on hand over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MNPR's cash on hand history?
The chart and table above show Monopar Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.